carteolol has been researched along with Conjunctival Neoplasms in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Conjunctival Neoplasms: Tumors or cancer of the CONJUNCTIVA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laaribi, N | 1 |
| Aachak, M | 1 |
| Chahdi, H | 1 |
| Alsubari, A | 1 |
| Dahi, S | 1 |
| Abdellaoui, T | 1 |
| El Asri, F | 1 |
| Reda, K | 1 |
| Oubaaz, A | 1 |
1 other study available for carteolol and Conjunctival Neoplasms
| Article | Year |
|---|---|
[Conjunctival hemangioma: From atypical presentation to topical beta-blocker treatment].
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Carteolol; Conjunctival Neoplasms; Hema | 2018 |